Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Reporting of Retrospective Registration in Clinical Trial Publications: a Cross-Sectional Study of German Trials

View through CrossRef
Objective: Prospective registration has been widely implemented and accepted as a best practice in clinical research, but retrospective registration is still commonly found. We assessed to what extent retrospective registration is reported transparently in journal publications, and investigated factors associated with transparent reporting. Design: We used a dataset of trials registered in ClinicalTrials.gov or Deutsches Register Klinischer Studien, with a German University Medical Center as the lead center, completed 2009-2017, and with a corresponding peer-reviewed results publication. We extracted all registration statements from results publications of retrospectively registered trials and assessed whether they mention or justify the retrospective registration. We analyzed associations of retrospective registration and reporting thereof with registration number reporting, International Committee of Medical Journal Editors (ICMJE) membership/-following and industry sponsorship using chi-squared or Fisher exact test. Results: In the dataset of 1927 trials with a corresponding results publication, 956 (53.7%) were retrospectively registered. Of those, 2.2% (21) explicitly report the retrospective registration in the abstract and 3.5% (33) in the full text. In 2.1% (20) of publications, authors provide an explanation for the retrospective registration in the full text. Registration numbers were significantly underreported in abstracts of retrospectively registered trials compared to prospectively registered trials. Publications in ICMJE member journals did not have statistically significantly higher rates of both prospective registration and disclosure of retrospective registration, and publications in journals claiming to follow ICMJE recommendations showed statistically significantly lower rates compared to non-ICMJE-following journals. Industry sponsorship of trials was significantly associated with higher rates of prospective registration, but not with transparent registration reporting. Conclusions: Contrary to ICMJE guidance, retrospective registration is disclosed and explained only in a small number of retrospectively registered studies. Disclosure of the retrospective nature of the registration would require a brief statement in the manuscript and could be easily implemented by journals.
Title: Reporting of Retrospective Registration in Clinical Trial Publications: a Cross-Sectional Study of German Trials
Description:
Objective: Prospective registration has been widely implemented and accepted as a best practice in clinical research, but retrospective registration is still commonly found.
We assessed to what extent retrospective registration is reported transparently in journal publications, and investigated factors associated with transparent reporting.
Design: We used a dataset of trials registered in ClinicalTrials.
gov or Deutsches Register Klinischer Studien, with a German University Medical Center as the lead center, completed 2009-2017, and with a corresponding peer-reviewed results publication.
We extracted all registration statements from results publications of retrospectively registered trials and assessed whether they mention or justify the retrospective registration.
We analyzed associations of retrospective registration and reporting thereof with registration number reporting, International Committee of Medical Journal Editors (ICMJE) membership/-following and industry sponsorship using chi-squared or Fisher exact test.
Results: In the dataset of 1927 trials with a corresponding results publication, 956 (53.
7%) were retrospectively registered.
Of those, 2.
2% (21) explicitly report the retrospective registration in the abstract and 3.
5% (33) in the full text.
In 2.
1% (20) of publications, authors provide an explanation for the retrospective registration in the full text.
Registration numbers were significantly underreported in abstracts of retrospectively registered trials compared to prospectively registered trials.
Publications in ICMJE member journals did not have statistically significantly higher rates of both prospective registration and disclosure of retrospective registration, and publications in journals claiming to follow ICMJE recommendations showed statistically significantly lower rates compared to non-ICMJE-following journals.
Industry sponsorship of trials was significantly associated with higher rates of prospective registration, but not with transparent registration reporting.
Conclusions: Contrary to ICMJE guidance, retrospective registration is disclosed and explained only in a small number of retrospectively registered studies.
Disclosure of the retrospective nature of the registration would require a brief statement in the manuscript and could be easily implemented by journals.

Related Results

Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Update on the clinical trial landscape: analysis of ClinicalTrials.gov registration data, 2000–2020
Update on the clinical trial landscape: analysis of ClinicalTrials.gov registration data, 2000–2020
Abstract Background The clinical trial landscape has evolved over the last two decades, shaped by advances in therapeutics and drug development and...
Current therapeutic strategies for erectile function recovery after radical prostatectomy – literature review and meta-analysis
Current therapeutic strategies for erectile function recovery after radical prostatectomy – literature review and meta-analysis
Radical prostatectomy is the most commonly performed treatment option for localised prostate cancer. In the last decades the surgical technique has been improved and modified in or...
Rotavirus vaccine clinical trials: a cross-sectional analysis of clinical trials registries
Rotavirus vaccine clinical trials: a cross-sectional analysis of clinical trials registries
Abstract Background Rotavirus is a primary infectious virus causing childhood diarrhoea and is associated with significant mortality in children. Th...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
Enhancing clinical evidence by proactively building quality into clinical trials
Enhancing clinical evidence by proactively building quality into clinical trials
Background: Stakeholders across the clinical trial enterprise have expressed concern that the current clinical trial enterprise is unsustainable. The cost and complexity of trials ...

Back to Top